Don Ponec Efficacy of venoplasty in MS(our study)... He presented the Hubbard Institute data on 265 patients. Clinical improvement at 1 and 6 months after treatment were statistically significant at the p < 0.01 level. 36.1% were markedly improved ,40.5% improved, 13.9%unchanged,8.2 % worse 1.3%markedly worse. Level of disability, MS subcategories, age and gender were not predictors of success.
If all of those are not predictors of success, do we have anything left that could be?
I would've thought lower disability was easier to recover from and/or indicated less spinal cord damage, which is hard to recover from.
I would've thought MS subcategories made a difference, with RR having a bigger effect and SP and/or PP less so.
I would've thought age would've made a difference, with younger patients responding better.
But with all of those out, what's left? I'd have to double-check CureIous's notes, I think he also had # of CCSVI sites treated on the list from Ponec as not a predictor of success.
It's encouraging, really, because it means this procedure could help anyone without regard to EDSS level, MS subcategory or age; there's no way to know until you go for it.